Compare RNA & AG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RNA | AG |
|---|---|---|
| Founded | 2025 | 1979 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.3M | 8.7B |
| IPO Year | 2025 | 2004 |
| Metric | RNA | AG |
|---|---|---|
| Price | $8.15 | $14.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $25.00 | $24.00 |
| AVG Volume (30 Days) | 215.9K | ★ 7.4M |
| Earning Date | 08-13-2026 | 11-05-2026 |
| Dividend Yield | N/A | ★ 0.30% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $84.55 | $36.78 |
| Revenue Next Year | N/A | $10.40 |
| P/E Ratio | ★ N/A | $143.01 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.49 | $10.19 |
| 52 Week High | $73.06 | $32.00 |
| Indicator | RNA | AG |
|---|---|---|
| Relative Strength Index (RSI) | 41.34 | 30.45 |
| Support Level | $7.63 | $14.11 |
| Resistance Level | $8.50 | $17.84 |
| Average True Range (ATR) | 0.35 | 0.59 |
| MACD | 0.17 | -0.11 |
| Stochastic Oscillator | 67.33 | 12.29 |
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
First Majestic Silver Corp is in the business of production, development, exploration, and acquisition of mineral properties with a focus on silver and gold production in North America. The company owns four producing mines in Mexico, consisting of the Santa Elena Silver/Gold Mine, the San Dimas Silver/Gold Mine, the Los Gatos Silver Mine, and the La Encantada Silver Mine. It also owns the Jerritt Canyon Gold Mine in Nevada, USA. Additionally, the firm holds interests in the San Martin Silver Mine and the Del Toro Silver Mine, and several exploration-stage projects. The majority of the company's revenues are from the sale of precious metals contained in dore and concentrate form. It generates maximum revenue from the sale of silver, followed by gold, zinc, copper, and other metals.